Найти
Результаты поиска
-
OPTIMIZATION OF COMPREHENSIVE TREATMENT OF LICHEN RUBER PLANUS: CLINICAL-IMMUNOLOGICAL STUDY
Objective: to study the clinical and immunological characteristics of various forms of LC and to evaluate the effectiveness of combined therapy using narrow-band UVB therapy (311 nm), excimer laser (308 nm), and topical tacrolimus. Materials and methods: The prospective study included 118 patients with verified CPL, randomized into 4 groups. The 1st group (n=28) received standard therapy (topic corticosteroids, antihistamines, vitamins), the 2nd group (n=29) received standard therapy + UVB-311, the 3rd group (n=30) received standard therapy + UVB-311 + excimer laser, the 4th group (n=31) received standard therapy + UVB-311 + excimer laser + tacropic cream. The effectiveness was assessed by the dynamics of LPASI, REU, VAS indices, cytokine levels (IL-6, IL-1β, IL-10), dermatoscopic picture, and quality of life (HADS). Results: The highest clinical effectiveness was noted in the 4th group: a decrease in the LPASI index by 85.1% (p<0.001), the REU index by 0.64±0.23 (p<0.01), and the intensity of itching by VAS by 82%. In this same group, normalization of the cytokine profile (IL-6, IL-1β, IL-10) and maximum improvement of the quality of life (reduction of anxiety and depression according to HADS by 77.2% and 87.8%, respectively) were recorded. Dermatoscopic signs of activity (Wickham's network, vascular patterns) regressed most significantly in the combined therapy groups. Conclusions: Combined CPL therapy, including UVB-311, 308 nm excimer laser, and topical tacrolimus, is a highly effective pathogenetically justified approach that provides not only clinical improvement but also normalization of immunological indicators and improvement of patients' quality of life.